The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNb Global Regulatory News (NBMI)

Share Price Information for Nb Global (NBMI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 51.40
Bid: 51.40
Ask: 53.80
Change: 0.00 (0.00%)
Spread: 2.40 (4.669%)
Open: 52.60
High: 53.80
Low: 51.40
Prev. Close: 52.60
NBMI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Move to liquidation accounting under US GAAP

6 Nov 2023 15:19

RNS Number : 5332S
NB Global Monthly Income Fund Ltd
06 November 2023
 

06 November 2023

 

NB GLOBAL MONTHLY INCOME FUND LIMITED

(the "Company")

(LSE: NBMI, LEI: 549300P4FSBHZFALLG04)

 

 

Move to liquidation accounting under US GAAP

 

The Company's Investment Policy was changed in January 2023 to pursue a Managed Wind-down strategy. Under US Generally Accepted Accounting Principles ("US GAAP") (the basis on which the Company accounts), a move to a Managed Wind-down strategy results in the need for the Company to prepare its annual audited financial statements under a liquidation basis of accounting. Therefore, this basis of accounting will be used for the financial statements of the year ending 31 December 2023.

 

US GAAP liquidation accounting requires the Company to accrue, in the financial year that a liquidation strategy is announced, all future ongoing operating fees and expenses that the Company might bear prior to actual liquidation. This accrual includes but is not limited to the Company's best estimate of all forward looking:

 

· Investment management and services fees

· Administration and professional fees

· Directors' fees

· Liquidation fees

 

 

As such and for the avoidance of doubt, this accrual includes all the estimated fees and expenses for the following financial year (2024) by the end of which the Company expects to be liquidated.

 

The Company's assessment of this accrual is approximately $900,000 (US dollars), 1.3% of the 2 November NAV. This accrual has been reflected in the 3 November NAV, announced today. The Board and Management will continue to reassess the accrual and adjust it as necessary as the Company progresses toward final liquidation, using best efforts to minimise costs.

 

For further information, please contact:

Neuberger Berman Europe Limited (Manager)

Elizabeth Papadopoulos

+44 (0) 20 3214 9078

Deutsche Numis (Broker)

Hugh Jonathan

Matt Goss

+44 (0) 20 7260 1000

Sanne Fund Services (Guernsey) Limited (Company Secretary)

Matt Falla

Gemma Berry

 

+44 (0) 20 3530 3600

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFLELDLRIIV
Date   Source Headline
26th Apr 20246:00 pmRNSNet Asset Value(s)
25th Apr 20246:00 pmRNSNet Asset Value(s)
25th Apr 20244:00 pmRNSDividend Declaration
24th Apr 20246:00 pmRNSNet Asset Value(s)
23rd Apr 20246:00 pmRNSNet Asset Value(s)
22nd Apr 20246:00 pmRNSNet Asset Value(s)
19th Apr 20246:00 pmRNSNet Asset Value(s)
18th Apr 20246:00 pmRNSNet Asset Value(s)
17th Apr 20246:00 pmRNSNet Asset Value(s)
17th Apr 20247:00 amRNSAnnual Financial Report
16th Apr 20246:00 pmRNSNet Asset Value(s)
15th Apr 20246:00 pmRNSNet Asset Value(s)
12th Apr 20246:00 pmRNSNet Asset Value(s)
11th Apr 20246:00 pmRNSNet Asset Value(s)
10th Apr 20246:00 pmRNSNet Asset Value(s)
9th Apr 20246:00 pmRNSNet Asset Value(s)
8th Apr 20246:00 pmRNSNet Asset Value(s)
4th Apr 20246:00 pmRNSNet Asset Value(s)
3rd Apr 20246:00 pmRNSNet Asset Value(s)
2nd Apr 20246:00 pmRNSNet Asset Value(s)
2nd Apr 202410:28 amRNSTotal Voting Rights
28th Mar 20246:00 pmRNSNet Asset Value(s)
27th Mar 20246:00 pmRNSNet Asset Value(s)
26th Mar 20246:00 pmRNSNet Asset Value(s)
25th Mar 20246:00 pmRNSNet Asset Value(s)
22nd Mar 20246:00 pmRNSNet Asset Value(s)
21st Mar 20246:00 pmRNSNet Asset Value(s)
20th Mar 20246:00 pmRNSNet Asset Value(s)
19th Mar 20246:00 pmRNSNet Asset Value(s)
18th Mar 20246:00 pmRNSNet Asset Value(s)
15th Mar 20246:00 pmRNSNet Asset Value(s)
14th Mar 20246:00 pmRNSNet Asset Value(s)
13th Mar 20246:00 pmRNSNet Asset Value(s)
12th Mar 20246:00 pmRNSNet Asset Value(s)
11th Mar 20246:00 pmRNSNet Asset Value(s)
8th Mar 20246:00 pmRNSNet Asset Value(s)
7th Mar 20246:00 pmRNSNet Asset Value(s)
7th Mar 20244:55 pmRNSDirector/PDMR Shareholding
7th Mar 202411:52 amRNSDirector/PDMR Shareholding
6th Mar 20246:00 pmRNSNet Asset Value(s)
5th Mar 20246:00 pmRNSNet Asset Value(s)
5th Mar 20247:00 amRNSReturn of Capital by Partial Compulsory Redemption
4th Mar 20246:00 pmRNSNet Asset Value(s)
1st Mar 20246:00 pmRNSNet Asset Value(s)
29th Feb 20246:00 pmRNSNet Asset Value(s)
28th Feb 20246:00 pmRNSNet Asset Value(s)
27th Feb 20246:00 pmRNSNet Asset Value(s)
26th Feb 20246:00 pmRNSNet Asset Value(s)
23rd Feb 20246:00 pmRNSNet Asset Value(s)
22nd Feb 20246:00 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.